Syneron Bio
1deals in 2026
$150.0Mraised
| Date | Type | Amount | Upfront | Investors / partner | Notes | Source |
|---|---|---|---|---|---|---|
| 31 Mar 2026 | Series B | $150.0M | — | Undisclosed international life-science fund (lead); Decheng Capital; CDH VGC; AstraZeneca; Temasek | Source |
| Date | Type | Amount | Upfront | Investors / partner | Notes | Source |
|---|---|---|---|---|---|---|
| 31 Mar 2026 | Series B | $150.0M | — | Undisclosed international life-science fund (lead); Decheng Capital; CDH VGC; AstraZeneca; Temasek | Source |